Excessive expression of synaptojanin in brains with Down syndrome

被引:65
作者
Arai, Y
Ijuin, T
Takenawa, T
Becker, LE
Takashima, S
机构
[1] Natl Ctr Hosp Mental Nervous & Muscular Disorders, Dept Clin Lab, Kodaira, Tokyo, Japan
[2] Univ Tokyo, Inst Med Sci, Dept Biochem, Tokyo 108, Japan
[3] Univ Toronto, Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada
关键词
Down syndrome; synaptojanin; Cajal-Retzius cells; ventricular neuroepithelium; neuronal migration;
D O I
10.1016/S0387-7604(01)00405-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We investigated the expression of synaptojanin, which has been mapped on 21q22.2 on human chromosome, in the cerebral cortex of patients with Down syndrome (DS), using immunohistochemistry and immunoblotting. Synaptojanin expression was observed in Cajal-Retzius cells, cortical plate neurons, subplate neurons, intermediate neurons, germinal matrix cells and the ventricular neuroepithelium of the fetal cerebrum in both controls and DS. After birth, synaptojanin immunoreactivity was mainly observed in cytoplasm of cortical neurons and neurophils. These expressions of synaptojanin suggest a broader role in not only synaptic vesicle recycling, but also the regulation of neuronal migration and synaptogenesis in the fetal period. In comparison with controls, DS brains clearly showed higher immunoreactivity of synaptojanin in every structure, and most of the large neurons showed immunoreactivity. Western blotting with synaptojanin confirmed the increased expression in DS brains. Although the reason for excessive expression of synaptojanin in DS brains is obscured, one possibility can be explained on the basis of a gene dosage effect. As another possibility, on the assumption that synaptojanin modulates synaptic transmission and plays roles in clathrin-mediated synaptic vesicle endocytosis and signaling, the excessive expression of synaptojanin may be involved in compensatory mechanisms occurring in developing DS brains, such as neuronal loss, atrophic basilar dendrites, decreased spines and abnormal synaptic density and length. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:67 / 72
页数:6
相关论文
共 23 条
[1]   10 years of genomics, chromosome 21, and Down syndrome [J].
Antonarakis, SE .
GENOMICS, 1998, 51 (01) :1-16
[2]   Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brains [J].
Arai, Y ;
Suzuki, A ;
Mizuguchi, M ;
Takashima, S .
BRAIN & DEVELOPMENT, 1997, 19 (04) :290-294
[3]  
ARIAS C, 1993, J NEUROCHEM, V61, P673
[4]   DENDRITIC ATROPHY IN CHILDREN WITH DOWNS-SYNDROME [J].
BECKER, LE ;
ARMSTRONG, DL ;
CHAN, F .
ANNALS OF NEUROLOGY, 1986, 20 (04) :520-526
[5]   Predominant localization of the LIS family of gene products to Cajal-Retzius cells and ventricular neuroepithelium in the developing human cortex [J].
Clark, GD ;
Mizuguchi, M ;
Antalffy, B ;
Barnes, J ;
Armstrong, D .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (09) :1044-1052
[6]   Essential role of phosphoinositide metabolism in synaptic vesicle recycling [J].
Cremona, O ;
Di Paolo, G ;
Wenk, MR ;
Lüthi, A ;
Kim, WT ;
Takei, K ;
Daniell, L ;
Nemoto, Y ;
Shears, SB ;
Flavell, RA ;
McCormick, DA ;
De Camilli, P .
CELL, 1999, 99 (02) :179-188
[7]   Assignment of SYNJ1 to human chromosome 21q22.2 and Synj12 to the murine homologous region on chromosome 16C3-4 by in situ hybridization [J].
Cremona, O ;
Nimmakayalu, M ;
Haffner, C ;
Bray-Ward, P ;
Ward, DC ;
De Camilli, P .
CYTOGENETICS AND CELL GENETICS, 2000, 88 (1-2) :89-90
[8]   ABNORMAL PERISOMATIC STRUCTURES IN NON-PYRAMIDAL NEURONS IN THE CEREBRAL-CORTEX IN DOWNS-SYNDROME [J].
FABREGUES, I ;
FERRER, I .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1983, 9 (02) :165-169
[9]   Direct interaction of the 170 kDa isoform of synaptojanin 1 with clathrin and with the clathrin adaptor AP-2 [J].
Haffner, C ;
Di Paolo, G ;
Rosenthal, JA ;
De Camilli, P .
CURRENT BIOLOGY, 2000, 10 (08) :471-474
[10]   3-DIMENSIONAL STRUCTURAL ORGANIZATION OF LAYER-I OF THE HUMAN CEREBRAL-CORTEX - A GOLGI-STUDY [J].
MARINPADILLA, M .
JOURNAL OF COMPARATIVE NEUROLOGY, 1990, 299 (01) :89-105